Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur la COVID en France - Analysis (France)

Index « Auteurs » - entrée « E. Salort-Campana »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
E. Raimond < E. Salort-Campana < E. Seizilles De Mazancourt  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000147 (2020) G. Solé [France] ; E. Salort-Campana [France] ; Y. Pereon [France] ; T. Stojkovic [France] ; K. Wahbi [France] ; P. Cintas [France] ; D. Adams [France] ; P. Laforet [France] ; V. Tiffreau [France] ; I. Desguerre [France] ; L I Pisella [France] ; A. Molon [France] ; S. Attarian [France]Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network.

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Angiotensin Receptor Antagonists (therapeutic use)
1Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
1Anti-Bacterial Agents (therapeutic use)
1Antimalarials (therapeutic use)
1Azithromycin (therapeutic use)
1Betacoronavirus (MeSH)
1Cardiorespiratory Fitness (MeSH)
1Coronavirus Infections (drug therapy)
1Coronavirus Infections (epidemiology)
1Emergency Treatment (MeSH)
1France (epidemiology)
1Glycogen Storage Disease Type II (therapy)
1Hospitalization (MeSH)
1Humans (MeSH)
1Hydroxychloroquine (therapeutic use)
1Immune System Diseases (therapy)
1Immunoglobulins, Intravenous (therapeutic use)
1Immunosuppressive Agents (therapeutic use)
1Muscular Atrophy, Spinal (drug therapy)
1Neuromuscular Diseases (therapy)
1Oligonucleotides (therapeutic use)
1Pandemics (MeSH)
1Physical Therapy Modalities (MeSH)
1Pneumonia, Viral (drug therapy)
1Pneumonia, Viral (epidemiology)
1Prognosis (MeSH)
1RNA, Small Interfering (therapeutic use)
1Steroids (therapeutic use)
1Withholding Treatment (MeSH)
1alpha-Glucosidases (therapeutic use)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "E. Salort-Campana" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "E. Salort-Campana" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    E. Salort-Campana
}}
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021